ATAI Life Sciences NV
NASDAQ:ATAI

Watchlist Manager
ATAI Life Sciences NV Logo
ATAI Life Sciences NV
NASDAQ:ATAI
Watchlist
Price: 1.19 USD Market Closed
Market Cap: 199.7m USD
Have any thoughts about
ATAI Life Sciences NV?
Write Note

ATAI Life Sciences NV
Cash Interest Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ATAI Life Sciences NV
Cash Interest Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
ATAI Life Sciences NV
NASDAQ:ATAI
Cash Interest Paid
$1.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Cash Interest Paid
€1.8B
CAGR 3-Years
15%
CAGR 5-Years
4%
CAGR 10-Years
14%
Merck KGaA
XETRA:MRK
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
MPH Health Care AG
XETRA:93M1
Cash Interest Paid
€575.8k
CAGR 3-Years
8%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Cash Interest Paid
€53.8m
CAGR 3-Years
89%
CAGR 5-Years
52%
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Cash Interest Paid
€4m
CAGR 3-Years
189%
CAGR 5-Years
267%
CAGR 10-Years
N/A
No Stocks Found

ATAI Life Sciences NV
Glance View

Market Cap
199.7m USD
Industry
Pharmaceuticals

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company engages in the treatment of mental health disorders. The company is headquartered in Berlin, Berlin and currently employs 81 full-time employees. The company went IPO on 2021-06-18. The firm is aiming to transform the treatment of mental health disorders.

ATAI Intrinsic Value
0.02 USD
Overvaluation 98%
Intrinsic Value
Price

See Also

What is ATAI Life Sciences NV's Cash Interest Paid?
Cash Interest Paid
1.9m USD

Based on the financial report for Dec 31, 2023, ATAI Life Sciences NV's Cash Interest Paid amounts to 1.9m USD.

What is ATAI Life Sciences NV's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 1Y
277%

Over the last year, the Cash Interest Paid growth was 277%.

Back to Top